Q2 2013

Filed Aug 14, 2013 · 10-Q · 45 days after period end · 0001144204-13-046070

Q2 2013 · 10-Q

Revenue

$272.00K

−17.6% vs Q2 2012

Net Income

-$11.59M

N/M vs Q2 2012

EPS Diluted

-$0.40

N/M vs Q2 2012

Operating Income-$11,404,000N/M

Free Cash Flow

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	$272.00K	$330.00K	$0.00	$0.00
Net Income	-$11.59M	-$10.15M	-$12.33M	-$8.73M
EPS Diluted	-$0.40	-$0.06	-$0.15	-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR